Skip to main content

Rheumatoid Arthritis

      RT @uptoTate: History of IBS, more aggressive disease phenotype & active SpA before conception or during pregnancy i
      History of IBS, more aggressive disease phenotype & active SpA before conception or during pregnancy increased the risk for adverse pregnancy outcome. #ABS1324 #ACR20 @RheumNow https://t.co/NQ6kDMSaJ3 https://t.co/I3sxRmPL6j
      Rheumatoid Arthritis and ILD: Dr. Janet Pope interviews Dr. Jeffrey Sparks

      Dr. Janet Pope talks with Dr. Jeffrey Sparks about abstracts #0392, #0491, #1198 and #0489 presented at the ACR annual meeting.   

      821 SLE pts from Hopkins lupus clinic showed that LAC was best predictor of venous + arterial thromboses. β2glycoprotei
      4 years ago
      821 SLE pts from Hopkins lupus clinic showed that LAC was best predictor of venous + arterial thromboses. β2glycoproteinI IgA (+) also important! #ACR20 #Abstr#1261 https://t.co/H0hz9Gp5Hy https://t.co/Vpiih4LyuZ
      RT @synovialjoints: In our quest to reduce delays to diagnosis in axSpA, this paper in patients with psoriasis, AAU and
      In our quest to reduce delays to diagnosis in axSpA, this paper in patients with psoriasis, AAU and IBD, the ASAS-modification of the Berlin algorithm was superior to the original algorithm, with enhanced sensitivity @RheumNow #ACR20 Abstr#1303
      RT @MeralElRamahiMD: Do you recommend Omega-3 fish oil (2-9 grams per day) to your patients with RA (doubled blinded RCT
      Do you recommend Omega-3 fish oil (2-9 grams per day) to your patients with RA (doubled blinded RCT in 140 pts w/ recent onset of RA showed increased likelihood of achieving remission & less failure of triple therapy in high-dose fish oil group). #ACR20 @RheumNow @LCalabreseDO
      RT @RHEUMarampa: This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/
      4 years ago
      This study shows that serum anti-PAD4, anti-PAD3/4XR abs are highly specific for RA-ILD and assoc'd w/ better lung function in RA-UIP. Small patient sample. Potential prognostic biomarker? @RheumNow #ACR20 abs1200 https://t.co/f5VFjJhVXF
      Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two: Targeting Plasmacytoid Dendritic Cells in Lupus…
      RT @RichardPAConway: Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score match
      Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS
      RT @drdavidliew: Nintedanib in rheum ILD (RA/SSc/CTD)
      I appreciate the volumes might not seem like much, but:
      - in first
      4 years ago
      Nintedanib in rheum ILD (RA/SSc/CTD) I appreciate the volumes might not seem like much, but: - in first 1y Rx 20% more are spared a FVC decline>10% - biggest diff in UIP-like pattern With the right patient selection, nintedanib does have its place! #ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
      Subclinical Synovitis: Dr Eric Dein

      Dr. Eric Dein reviews abstract #0481 presented at the 2020 ACR annual meeting, and reviews the Twitter poll he posted on whether clinicians would start DMARDs in this scenario.